Title: Cost-Effectiveness of Care Models to Support HCV and HIV Elimination in People Who Inject Drugs

Bruce Schackman, Phd
Weill Cornell Medical College

ABSTRACT:
The United States has set ambitious goals to eliminate Hepatitis C Virus (HCV) and HIV infections nationally, but the current opioid crisis has resulted in increased incidence of HCV as well as outbreaks of HIV among people who inject drugs (PWID). PWID may not access healthcare services because of stigma, abstinence requirements, and lack of available providers. This presentation will describe recent and ongoing work evaluating the effectiveness, cost-effectiveness, and implementation of different healthcare models designed to bring HCV/HIV testing and HCV care to PWID in a variety of settings including methadone maintenance programs, syringe service programs, and clinical settings.